Lountzis Asset Management JNJ trades
Paul Lountzis
Paul Lountzis Johnson & Johnson stake
total: 145
Trades details
- Total transactions:
- 11
- New positions:
- 2
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 1
- Held since:
- 2023 Q1
- Held for:
- 15 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Paul Lountzis holds 2,789 Johnson & Johnson (JNJ) shares with a market value of roughly $738.36K accounting for 0.24% of the overall portfolio. To date, the estimated cost basis is nearly $168.93 for "buy" trades and estimated average "sell" price is $264.74. Lountzis Asset Management first purchased JNJ in 2020 Q2, initially acquiring 1,237 shares. Paul Lountzis later completely sold out the position and invested in Johnson & Johnson again in 2023 Q1. Since the initial investment in Johnson & Johnson (JNJ), Lountzis Asset Management has made 10 more transactions.
When did Paul Lountzis buy Johnson & Johnson (JNJ)?
Paul Lountzis first invested in Johnson & Johnson (JNJ) in 2020 Q2 at the reported quarter-end price of $140.66 per share.
What's the cost basis of Lountzis Asset Management's JNJ stake?
The estimated cost basis for Johnson & Johnson (JNJ) stake is around $168.93 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $168.93
- Weighted AVG sell price:
- $264.74
Paul Lountzis's historical trades in Johnson & Johnson
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.24%
|
2,789
|
$264.74
|
$738,360
|
-4.22% (-123)
|
-0.01%
|
|
2026 Q2
|
0.23%
|
2,912
|
$253.97
|
$739,561
|
+7.06% (+192)
|
+0.02%
|
|
2026 Q1
|
0.24%
|
2,720
|
$244.44
|
$664,876
|
+4.98% (+129)
|
+0.01%
|
|
2025 Q4
|
0.19%
|
2,591
|
$206.95
|
$536,207
|
+3.14% (+79)
|
+0.01%
|
|
2025 Q1
|
0.15%
|
2,512
|
$155.35
|
$390,239
|
+12.24% (+274)
|
+0.02%
|
|
2024 Q3
|
0.15%
|
2,238
|
$162.06
|
$362,690
|
+57.49% (+817)
|
+0.06%
|
|
2024 Q1
|
0.11%
|
1,421
|
$158.19
|
$224,788
|
+1.79% (+25)
|
+0%
|
|
2023 Q4
|
0.12%
|
1,396
|
$156.74
|
$218,809
|
+1.09% (+15)
|
+0%
|
|
2023 Q1
|
0.13%
|
1,381
|
$154.96
|
$214,000
|
new
|
+0.13%
|
|
2022 Q3
|
0.00%
|
0
|
$177.04
|
|
-100% (-1,237)
|
-0.15%
|
|
2020 Q2
|
0.16%
|
$140.66
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.